Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma.
Johannes WachÁgi GüresirValeri BorgerPatrick SchussAlbert BeckerChristoph CochMarie-Therese SchmitzMichael HölzelMarieta TomaUlrich HerrlingerHartmut VatterErdem GüresirPublished in: Journal of neuro-oncology (2021)
The baseline CRP level thus serves as an independent predictor of PFS. Further investigations of the role of inflammation and tumor inflammatory microenvironment in the prediction of prognosis in sporadic VS are needed.